Prevnar 13 In Older Adults Appears To Have Smooth Path To FDA Approval

Advisory committee to give recommendations on the Pfizer vaccine’s safety and immunogenicity using accelerated approval, but no votes mentioned.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America